ERBB2 and neoplasm: Susceptibility to that retargeted virus infection and replication was studied on human breast cancer SK-OV-3 cells and anti-tumour activity at Lewis lung carcinoma murine cell line expressing hHER2 (HER2-LLC1) subcutaneous (s.c.)tumours.